RecruitingNCT03581318

Technical and Translational Development of Cardiovascular Magnetic Resonance (CMR) Imaging

Technical and Translational Development of Cardiovascular MRI (CMR)


Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Enrollment

5,000 participants

Start Date

Jul 12, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

Background: Magnetic resonance imaging (MRI) is an important non-invasive tool to study and diagnose cardiovascular disease. MRI scanners use strong magnetic fields and radio waves to create pictures of body organs. Researchers want to find better MRI methods and new ways of imaging cardiovascular disease and better understand normal and abnormal cardiovascular and brain function. Researchers are also interested in seeing if gadolinium, the commonly used MRI contrast agent, stays in the body long after the MRI was performed. Objectives: To develop new methods for imaging the heart and other organs of the body. To describe cardiovascular diseases using newer MRI methods To look at the relationship between cardiovascular disease and cardiovascular risk factors and other organ systems To look for gadolinium deposits in the brain from prior exams. Eligibility: Healthy people and people with known or suspected cardiovascular disease ages 7 and older may be eligible for this study. Researchers may be particularly interested in those who: * Have suspected or known cardiovascular disease * Were previously exposed to a gadolinium-based contrast agent, * Need to have a heart MRI scheduled * Need a test of the heart or other body part or will be undergoing a future cardiac catheterization Design: There are multiple arms to the study with optional components; therefore, there are multiple variations as to what an individual participant s experience may involve. Participants will have an MRI scan lasting up to 2 hours. The scanner is a large hollow tube. During the scan, there may be loud knocking and buzzing sounds caused by the scanner. Participants will lie on a table that slides in and out of the tube. Their vital signs may be monitored. Participants may have a test of heart electrical activity using wires connected to pads on the skin. Participants may have blood drawn. Participants may be injected with an MRI contrast agent through a plastic tube inserted in the arm.


Eligibility

Min Age: 7 YearsMax Age: 100 Years

Plain Language Summary

Simplified for easier understanding

This study develops and improves new MRI (magnetic resonance imaging) techniques for looking at the heart and blood vessels, with the goal of creating better, faster, and more detailed heart scans for both healthy people and those with heart conditions. **You may be eligible if...** - You are 7 years of age or older - You are able to follow instructions and lie still in an MRI scanner - You currently do not have any known cardiovascular (heart or blood vessel) disease - You are able to provide informed consent (or a parent or guardian can consent for you) - You are willing to cooperate with all study procedures **You may NOT be eligible if...** - You have a significant medical history including conditions like a previous heart attack, congenital heart disease, or known cardiomyopathy (heart muscle disease) - You have any condition that makes MRI unsafe (such as a pacemaker or certain metal implants) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

National Institutes of Health Clinical Center

Bethesda, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03581318